Previous studies have shown that low-carb diets or SGLT2 inhibitors can increase plasma ketones in humans. This proof-of-concept study will test the idea that a combination of both can safely increase plasma ketones in healthy volunteers.
The purpose of this study is to help us better understand how plasma ketones respond to a low-carb diet when combined with an SGLT2 inhibitor.